706 results on '"Munoz, Flor M."'
Search Results
2. CONTRIBUTORS
3. Immunophenotypic predictors of influenza vaccine immunogenicity in pediatric hematopoietic cell transplant recipients
4. Thrombosis with thrombocytopenia syndrome (TTS) and vaccine-induced immune thrombocytopenia and thrombosis (VITT): Brighton Collaboration case definitions and guidelines for data collection, analysis, and presentation of immunisation safety data
5. Body surface area compared to body weight dosing of valganciclovir is associated with increased toxicity in pediatric solid organ transplantation recipients
6. Safety of COVID-19 vaccines during pregnancy: A systematic review and meta-analysis
7. Anosmia: Brighton Collaboration case definition and guidelines for data collection, analysis, and presentation of immunization safety data
8. Cumulative Febrile, Respiratory, and Gastrointestinal Illness Among Infants in Rural Guatemala and Association With Neurodevelopmental and Growth Outcomes
9. COVID-19 booster vaccination during pregnancy enhances maternal binding and neutralizing antibody responses and transplacental antibody transfer to the newborn
10. Respiratory syncytial virus prevention within reach: the vaccine and monoclonal antibody landscape
11. Multi-site observational maternal and infant COVID-19 vaccine study (MOMI-vax): a study protocol
12. Epidemiology and long-term outcomes of cytomegalovirus DNAemia and disease in pediatric solid organ transplant recipients
13. Incidence Rates of Medically Attended COVID-19 in Infants Less Than 6 Months of Age
14. Validating Claims-Based Algorithms Determining Pregnancy Outcomes and Gestational Age Using a Linked Claims-Electronic Medical Record Database
15. Safety of components and platforms of COVID-19 vaccines considered for use in pregnancy: A rapid review
16. Multicenter Analysis of Valganciclovir Prophylaxis in Pediatric Solid Organ Transplant Recipients.
17. Postnatal Zika and Dengue Infection and Their Effects on Neurodevelopment Among Children Living in Rural Guatemala
18. 1755. Hospitalizations for Respiratory Viruses among Children 5–17 Years of Age in the Pre-COVID-19 Pandemic Era, the New Vaccine Surveillance Network, 2016–2020
19. 385. Safety and Immunogenicity of a Variant-adapted Bivalent (Original/Omicron BA.4/BA.5) BNT162b2 COVID-19 Vaccine Given as a Booster (Dose 4) to 5- to 11-Year-Old Children Who Previously Received 3 Doses of Original BNT162b2
20. 546. COVID-19 Monoclonal Antibody Use at a Stand Alone Children’s Hospital
21. 544. Outpatient Remdesivir Use at a Stand Alone Children's Hospital
22. 362. Safety and Immunogenicity of a Variant-adapted Bivalent (Original/Omicron BA.4/BA.5) BNT162b2 COVID-19 Vaccine Given as a Booster (Dose 4) to Toddlers and Children 6 Months to < 5 Years of Age Who Previously Received Original BNT162b2 as a 3-Dose Primary Series
23. 462. Infant antibody titers at birth following maternal COVID-19 vaccination and protection against infection in the first 6 months of life
24. 1101. Antiviral Prescription in Children with Influenza in Emergency Departments (ED): New Vaccine Surveillance Network (NVSN), 2016–2020
25. 1742. Predictors of Antiviral Receipt for Influenza in Hospitalized U.S. Children, New Vaccine Surveillance Network (NVSN), 2016–2020
26. Maternal and perinatal health research during emerging and ongoing epidemic threats: a landscape analysis and expert consultation
27. Applicability of the GAIA Maternal and Neonatal Outcome Case Definitions for the Evaluation of Adverse Events Following Vaccination in Pregnancy in High-income Countries
28. Posttransplant Complications and Comorbidities
29. Timing of influenza vaccination during pregnancy
30. Nontuberculous and tuberculous Mycobacterium
31. Contributors
32. The Power of Connections: AAP COVID-19 ECHO Accelerates Responses During a Public Health Emergency
33. Chapter 305 - Influenza Viruses
34. Remdesivir for COVID-19 in Hospitalized Children: A Phase 2/3 Study.
35. Safety and Immunogenicity of Live Viral Vaccines in a Multicenter Cohort of Pediatric Transplant Recipients
36. A Cross-sectional Surveillance Study of the Frequency and Etiology of Acute Respiratory Illness Among Pregnant Women
37. Global considerations on maternal vaccine introduction and implementation
38. Respiratory syncytial virus
39. Contributors
40. Anosmia: Brighton Collaboration case definition and guidelines for data collection, analysis, and presentation of immunization safety data
41. A Review of Therapeutics in Clinical Development for Respiratory Syncytial Virus and Influenza in Children
42. Respiratory Syncytial Virus Vaccination During Pregnancy and Effects in Infants
43. Identifying Gaps in Respiratory Syncytial Virus Disease Epidemiology in the United States Prior to the Introduction of Vaccines
44. Standardizing case definitions for monitoring the safety of maternal vaccines globally: GAIA definitions, a review of progress to date
45. 26 - Viral Exanthems
46. Are the first 1,000 days of life a neglected vital period to prevent the impact on maternal and infant morbimortality of infectious diseases in Latin America? Proceedings of a workshop of experts from the Latin American Pediatric Infectious Diseases Society, SLIPE.
47. Standardizing case definitions for monitoring the safety of maternal vaccines globally: GAIA definitions, a review of progress to date
48. Guideline for collection, analysis and presentation of safety data in clinical trials of vaccines in pregnant women
49. Guidance for the collection of case report form variables to assess safety in clinical trials of vaccines in pregnancy
50. Preterm birth: Case definition & guidelines for data collection, analysis, and presentation of immunisation safety data
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.